Evaluation method of cholesterol-lowering agents lack rationale, civic groups say

Published: 2008-11-20 06:52:00

Updated: 2008-11-20 06:52:00

Civic groups advocating consumer rights, including the Korean Pharmacists for Democratic Society (KPRS), said in a recent statement that Pfizer and AstraZeneca profiteered 30.7 billion won due to the Health Insurance Review and Assessment Service’s biased cost-effectiveness evaluation on Lipitor ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK